Previous close | 0.5400 |
Open | 0.5500 |
Bid | 0.5750 x N/A |
Ask | 0.5800 x N/A |
Day's range | 0.5450 - 0.5750 |
52-week range | 0.4080 - 0.9550 |
Volume | |
Avg. volume | 152 |
Market cap | 684.204M |
Beta (5Y monthly) | 0.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.01 (2.19%) |
Ex-dividend date | 03 July 2024 |
1y target est | N/A |
The World Bank recently released its updated "Global Economic Outlook" report, projecting a 2.1% global economic growth for 2023. This forecast represents an upward revision of 0.4 percentage points compared to the previous prediction in January, yet it still falls short of the 3.1% growth anticipated for 2022. At present, the global economy remains in a recovery phase, and businesses continue to confront a multitude of risks. In the post-pandemic era, it becomes particularly essential for compa
June 26th, 2023, Pharmadule Morimatsu and WuXi Biologics officially entered into a global strategic cooperation for the Singapore CRDMO Center project of WuXi Biologics.